Insider Transactions in Q3 2021 at Re Shape Lifesciences Inc. (RSLS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2021
|
Dan W Gladney Director |
SELL
Open market or private sale
|
Direct |
200,000
-41.33%
|
$400,000
$2.99 P/Share
|
|
Sep 10
2021
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
48,366
-11.9%
|
$96,732
$2.89 P/Share
|
|
Sep 10
2021
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
294,494
-24.83%
|
$588,988
$2.89 P/Share
|
|
Aug 30
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+31.5%
|
$45,000
$3.43 P/Share
|
|
Aug 20
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+45.99%
|
$45,000
$3.22 P/Share
|
|
Jul 22
2021
|
Lori Courtney Mc Dougal Director |
BUY
Grant, award, or other acquisition
|
Direct |
253,429
+50.0%
|
-
|
|
Jul 22
2021
|
Arda Phd Minocherhomjee Director |
BUY
Grant, award, or other acquisition
|
Direct |
253,429
+50.0%
|
-
|
|
Jul 22
2021
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
253,429
+50.0%
|
-
|
|
Jul 22
2021
|
Dan W Gladney Director |
BUY
Grant, award, or other acquisition
|
Direct |
483,922
+50.0%
|
-
|
|
Jul 22
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
372,744
+32.69%
|
-
|
|
Jul 22
2021
|
Barton P. Bandy President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,186,006
+33.0%
|
-
|